AzTrials
AzTrials

SuicideNCT05869552

Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care

A study testing STAT-PC and YST-III in people with Suicide and Suicidal Ideation, run by Elizabeth Arnold at 3 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The overall aim of this study is to reduce suicide among sexual and gender diverse youth ages 18-24 years old. This study will compare the effectiveness of two brief suicide prevention interventions that have been adapted for use with this population to use in primary care via telehealth and will recruit youth from… Read more about this study

Who is it for?
Ages 18 to 24 years
Conditions the study is for
Suicide, Suicidal Ideation
What is being tested?
STAT-PC and YST-III
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,485 participants
Where
3 sitesUnited States
Study dates
13 Jul 2023to Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 24 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • be aged 18-24 at the time of enrollment
  • not have received mental health services in the past 90 days, excluding medication and case management
  • English-speaking
  • screen positive for suicide risk

Who cannot join

  • are actively suicidal
  • have a developmental disability that would preclude them from participating in the study intervention
  • who are impaired due to psychosis, mania, or substance use that would prevent them from providing consent.
  • Participants will also be excluded at YST-III sites if they are unable to identify a minimum of one support person to participate in the intervention with them

Trial locations and contacts

3 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Elizabeth Arnold, PhD contact

859-562-3751

Liz.Arnold@uky.edu

United States3 sites, 3 recruiting
  • Steve Hicks School of Social Work at the University of Texas at Austin

    Austin, Texas, 78705

    Lauren Gulbas, PhD

    Recruiting
  • University of Texas Southwestern Medical Center

    Dallas, Texas, 75390

    Emily Levy-Kamugisha, MD

    Recruiting
  • University of Pittsburgh

    Pittsburgh, Pennsylvania, 15261

    Phillip Schnarrs, PhD

    Recruiting

Other trials in United States

About this study

Official title: Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care: CRT

The overall aim of this study is to reduce suicide among sexual and gender diverse youth ages 18-24 years old. This study will compare the effectiveness of two brief suicide prevention interventions that have been adapted for use with this population to use in primary care via telehealth and will recruit youth from primary care clinics in multiple metropolitan areas. The primary study outcome is suicidal ideation. Each clinic will be randomly assigned to deliver one of the two study interventions.

Being tested
STAT-PC, YST-III
Keywords
depression, Self-Injurious Behavior, sexual and gender minority youth
Medical subject headings
Suicide, Suicidal Ideation, Depression, Self-Injurious Behavior, Coitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • STAT-PCOther

    Also called Suicidal Teens Accessing Treatment - Primary Care

    STAT-PC is an adapted version of Suicidal Teens Accessing Treatment after an ED Visit (STAT-ED). It is a brief intervention based on motivational interviewing (MI) that focuses on mental health care seeking behavior, problem-solving, and referrals plus brief case management. The intervention will consist of an initial session with the youth focusing on accessing mental health care plus case management calls. The interventionist will also be available to assist with referrals for connection to other services later during the study period as needed for up to three months. The intervention may include contact with the youth's mental health provider to make sure linkages are made.

  • YST-IIIOther

    Also called Youth-Nominated Support Team- III

    YST-III is an adapted version of Youth-Nominated Support Team for Suicidal Adolescents (YST-II). The intervention is a brief intervention originally developed for youth who have been psychiatrically hospitalized due to a suicide attempt or suicidal ideation (SI). Participants will nominate supportive adults (age 18 and older) from their lives who agree to provide ongoing contact and support for up to 3 months. YST-III will include an introductory session with the youth who will nominate their support persons plus referrals for mental health services. The support persons will receive training and support on how to best support their youth partner and then ongoing calls to support them in working with their youth partner for up to 3 months.

Study groups in NCT05869552
Study groupRoleWhat they receive
Suicidal Teens Accessing Treatment - Primary Care (STAT-PC)ExperimentalThis group will participate in a brief, suicide prevention intervention based on motivational interviewing that focuses on mental health care seeking behavior, problem-solving, and referrals plus brief case management that has been adapted.
Receives: Other: STAT-PC
Youth-Nominated Support Team (YST-III)ExperimentalThis group will participate in a brief, suicide prevention intervention originally developed for youth who have been psychiatrically hospitalized due to a suicide attempt or suicidal ideation that has been adapted.
Receives: Other: YST-III

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in suicidal ideation as measured by the Adult Suicidal Ideation Questionnaire (ASIQ)

    ASIQ is a 25-item, self-report assessment of suicidal thoughts designed specifically for adult populations. Possible scores range from 1 (Not at All) to 6 (Extreme), with lower scores indicating less severe suicidal ideation (better outcome).

    Measured: baseline and months 1, 3, 6

Secondary outcomes (6)
  1. Change in number of mental healthcare service utilization as measured by Emergency Department Screen for Teens at Risk for Suicide (ED-STARS) mental health service utilization check list

    ED-STARS mental health service utilization check list will be used to assess the number of different types of mental health services that participants receive

    Measured: baseline and months 1, 3, 6

  2. Change in number of suicide attempts

    measured by the number of suicide attempts using the Columbia-Suicide Severity Rating Scale (CSSRS)

    Measured: baseline and months 1, 3, 6

  3. Deaths by suicide

    The data on any reported deaths due to suicide during the study period will be collected.

    Measured: baseline to 6 months

  4. Change in depressive symptoms as measured by Center for Epidemiologic Studies Depression Scale-Revised CESD-R

    CESD-R is a 20-item measure of depression that assesses the duration symptoms across a period of two weeks. Possible scores range from 0-60, with lower scores indicating less depressive symptoms (better outcome).

    Measured: baseline and months 1, 3, 6

  5. Change in social support as measured by the Multidimensional Scale of Perceived Social Support (MSPSS)

    12-item measure with three subscales that assesses family, friend, and significant other support. Response categories are on a 7-point Likert-scale from 1=very strongly disagree to 7=very strongly agree. The overall score will be used to assess change. The 12-item MSPSS scale has a mean continuous score ranging from 1-84. Higher scores indicate greater perceived social support (better outcome).

    Measured: baseline and months 1, 3, 6

  6. Change in internalized stigma as measured by Internalized Transphobia Scale (ITS)-adapted

    an adapted version of the Internalized Transphobia Scale (ITS). The measure consists of 22 questions. Possible score ranges from 1-4 with lower scores indicating less internalized stigma (better outcome)

    Measured: baseline and months 1, 3, 6

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 May 2023
  2. Study start13 Jul 2023
  3. Primary completionMar 2027 (estimated)
  4. Study completionMar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
1,485 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05869552
Sponsor's protocol ID
86014
Other IDs
SP-2020C3-21020-IC
Status last verified
Nov 2025
First submitted
11 May 2023
Last updated
6 Nov 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified data will be deposited in the Patient-Centered Outcomes Data Repository as required by the funder.

Questions about this trial

What is this clinical trial studying?

A study testing STAT-PC and YST-III in people with Suicide and Suicidal Ideation, run by Elizabeth Arnold at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 6 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Elizabeth Arnold, PhD (859-562-3751, Liz.Arnold@uky.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in suicidal ideation as measured by the Adult Suicidal Ideation Questionnaire (ASIQ) (time frame: baseline and months 1, 3, 6). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Nov 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in